Archive

  • Select all
    |
  • KUANG Zheng-yue, ZHU Wei-min
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Pseudomonas aeruginosa is a common pathogen of hospital-acquired infection. Its strong drug resistance poses a great challenge to clinical treatment. Cefiderocol is a novel siderophore cephalosporin and has strong in vitro and in vivo antibacterial activity against a number of Gram-negative bacteria, including carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Enterobacteriaceae. In this article, the mechanism of action and in vitro activity of cefiderocol, the clinical study on Pseudomonas aeruginosa infection, and the antimicrobial resistance patterns of Pseudomonas aeruginosa to cefiderocol are reviewed, to provide a reference for the clinical application of cefiderocol against Pseudomonas aeruginosa infection.
  • SUN Gui-ying, NI Xiao-yan, LI Ying, XU Su
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To analyze the diagnosis and treatment process of one patient with orbital cellulitis and bloodstream infection caused by Streptococcus constellatus, and provide a reference for the clinical diagnosis and treatment of similar patients. Methods and Results: The patient (male, 60 years old) was admitted to the hospital due to "redness and swelling of the right eye for 10 days with suppuration for 1 week". After admission, the physical examination showed that the patient's right eye was severely swollen, with a lot of yellow-white purulent secretions; the laboratory test results of serum showed that the infection indicators such as white blood cell count, neutrophil percentage, C-reactive protein, procalcitonin, etc. were slightly high. Considering that the pathogens of eye infection were mostly Gram-positive bacteria and the combined intracranial infection could not be ruled out, linezolid + piperacillin-tazobactam sodium was given empirically, supplemented with debridement and drainage; on the next day, the blood culture result showed the presence of Streptococcus constellatus; on the third day, Streptococcus constellatus was also detected in the purulent secretion specimens, and the drug susceptibility test results showed that it was sensitive to penicillin, erythromycin, clindamycin, levofloxacin, and ceftizoxime. In combination with the patient's poor blood glucose control, poor oral hygiene, and presence of chronic sinusitis, among other conditions, Streptococcus constellatus was considered to be the pathogen of this infection, and the possibility of methicillin-resistant Staphylococcus aureus infection was ruled out, so linezolid was discontinued; but piperacillin-tazobactam sodium continued to be used for its good antibacterial effect. After 13 days of anti-infection treatment, the patient's symptoms such as redness and swelling, and suppuration of right eye and the infection indicators were significantly improved. Conclusion: As a common bacterium on the body surface and in the oral and nasal cavities, Streptococcus constellatus rarely causes infection in normal people, but has significantly increased risk of infection in people with poor basic conditions. Therefore, it is necessary to identify the pathogens clinically, so as to provide guidance for targeted anti-infection treatment.
  • WANG Yan, LIANG Yue
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To analyze the anti-infection treatment and pharmaceutical care of one patient with osteomyelitis and obesity, and provide a reference for the clinical anti-infection treatment of obese patients. Methods and Results: The patient was admitted to the hospital due to "swelling and pain of right knee joint with limited activity for more than 10 days". After admission, the patient was empirically given cefuroxime for anti-infection treatment. On the next day, the serological test showed that the patient's infection indicators such as white blood cell count, neutrophil percentage, C-reactive protein, procalcitonin, etc. were significantly abnormal. Since the patient has the history of fracture and osteomyelitis, the disease of osteomyelitis was considered this time, so cefuroxime was changed to piperacillin-tazobactam sodium. Two days later, the debridement and drainage were performed, and pus was taken for pathogenic examination. Staphylococcus aureus was detected, which was sensitive to methicillin and levofloxacin. According to the patient's pathogenic results and past medical history, the pathogen was likely to have biofilm; in addition, during the use of piperacillin-tazobactam sodium, wheal-like rashes occurred twice, so the anti-infection treatment regimen was switched to levofloxacin + rifampicin. Since levofloxacin is a fat-soluble drug, and the patient's height and body weight meet the obesity criteria, it was recommended that the dosage of levofloxacin should be "0.75 g, q24h". Nearly two weeks later, the patient's symptoms and infection indicators were significantly improved, so the patient was allowed to be discharged. Conclusion: For obese patients, full consideration should be given to the in vivo pharmacokinetic characteristics of drugs when developing a clinical dosing regimen, to ensure that the drugs reach effective therapeutic concentrations and thus improve the patient's therapeutic effect.
  • CAI Hai-feng, PAN Xiao-jun
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To analyze the epidemiological characteristics of adverse drug reactions related to tenofovir disoproxil fumarate (TDF) based on the US FDA Adverse Event Reporting System (FAERS) database, and provide a reference for the clinical medication safety of TDF. Methods: By using "tenofovir disoproxil fumarate" as a key word, all information on TDF-related adverse drug events (ADEs) from January 1, 2004 to December 31, 2022 was searched in the FAERS database, to analyze the epidemiological characteristics of the TDF-related adverse drug reactions. Results: A total of 69 352 cases of TDF-related ADEs were searched from the FAERS database, of which the number gradually increased from 584 in 2004 to 5 329 in 2019, and then sharply increased to 20 997 in 2020, and then decreased rapidly. Among the 69 352 cases of TDF-related ADEs, the reporting country was mainly the United States (47 050 cases, 67.84%), the reported severity was mainly "serious" (57 989 cases, 83.62%), the sex of patients involved was mainly male (43 746 cases, 63.08%), and their ages were mainly in the range of 18-64 years old (38 802 cases, 55.95%). The 69 352 ADEs involved 113 ADE positive signals and 19 system organ classes. The top three reported ADEs were renal and urinary disorders (24 168 cases), musculoskeletal and connective tissue disorders (23 432 cases), and psychiatric disorders (11 305 cases). In addition, among the 69 352 ADEs, 37 ADE signals were not mentioned in the TDF package insert, of which the top three ADEs were osteonecrosis (10 286 cases), miscarriage (1 043 cases), and vitamin D deficiency (880 cases), and the top five signal intensities were abnormal total protein, osteonecrosis, mitochondrial poisoning, abnormal ultrasound prenatal screening, and increased β2 microglobulinuria. Conclusion: Most TDF-related ADEs are serious. For ADEs that involve a large number of patients, especially those with positive signals not described in the TDF package insert, safe medication monitoring should be strengthened clinically, and active preventive and therapeutic measures should be taken to ensure the safe medication of patients.
  • GU Wen-wen, ZHANG Lei
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To analyze the clinical characteristics of adverse drug reactions (ADRs) related to antibacterial drugs reported by the hospital from 2019 to 2023, and provide a reference for further improving the clinical medication safety of antibacterial drugs. Methods: A total of 239 reports of antibacterial drug-related ADRs reported to the National Adverse Drug Reaction Monitoring System by Affiliated Jiangsu Shengze Hospital of Nanjing Medical University from January 2019 to December 2023 were selected as the research data. The information such as patients' age and sex, types and dosage forms of involved drugs, and clinical manifestations and outcomes of ADRs was collected to analyze the epidemiological characteristics of antibacterial drug-related ADRs. Results: Among the 239 reports of antibacterial drug-related ADRs, the number of female patients involved was slightly more than that of male patients (126 cases vs 113 cases), and the age distribution was overall balanced; a total of 245 cases with antibacterial drugs were involved among the 239 ADRs, of which, cephalosporins involved were most common (129 cases), followed by quinolones (62 cases); the drugs were mostly administered by intravenous drip (223 cases); the antibacterial drug-related ADRs mainly involved the skin and its appendages, followed by the digestive system. In terms of types of ADRs, most ADRs were "general" (183 cases) and "new and general" (42 cases), and only 12 cases and 2 cases of ADRs were "serious" and "new and serious" respectively. After treatment, the vast majority (235 cases, 98.33%) of patients were cured or alleviated. Conclusion: Most of the ADRs related to antibacterial drugs are caused by cephalosporins and quinolones in the hospital, and are not serious and have good outcomes. However, it is still necessary to strengthen the clinical monitoring of patients' medication to ensure the safe medication of patients.
  • ZHANG Hao
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To explore and analyze the adverse drug events (ADEs) of oxcarbazepine in the real world based on the US FDA Adverse Event Reporting System (FAERS) database, and provide a reference for the clinical medication safety of oxcarbazepine. Methods: By using "oxcarbazepine" as a key word, ADEs with oxcarbazepine as the primary suspected drug from May 1, 2018 to May 1, 2023 were searched in the FAERS database, and the related information on ADEs was collected to analyze the epidemiological characteristics of oxcarbazepine-related ADEs. Results: A total of 4 287 cases of oxcarbazepine-related ADEs that met the criteria were searched from the FAERS database, most of which were from the United States (3 288 cases, 76.70%), and most of the patients involved were aged 18-50 years old (2 041 cases, 47.61%). The 4 287 cases of oxcarbazepine-related ADEs involved 142 ADE signals and 20 system organ classes, among which the numbers of signals (34) and cases (1 744 cases) of various nervous system disorders were the most. Among the 4 287 cases of ADEs, the top five preferred terms (PTs) in terms of occurrence frequency were seizure, somnolence, focal epileptic seizures with cognitive impairment, fatigue and hyponatremia, and the top three PTs in terms of reporting odds ratio signal intensity were simple partial seizures, partial epilepsy followed by generalized seizures, and focal epileptic seizures with cognitive impairment. Among the 142 ADE signals, after the signals unrelated to the adverse drug reactions of oxcarbazepine itself were excluded, there were still 109 signals, of which 23 are not described in the oxcarbazepine package insert. Conclusion: Many oxcarbazepine-related ADEs are manifested as nervous system reactions, and some of them are similar to the drug indications, which should be identified during clinical monitoring of the adverse drug reactions of oxcarbazepine to ensure the safe medication of patients.
  • ZHANG Yu, YAN Bin, GU Yu-han
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To analyze the practice of pediatric clinical pharmacists participating in anti-infection consultation and provide a reference for the safe and rational use of drugs in clinically infected children. Methods: Four typical cases of anti-infection consultation participated by pediatric clinical pharmacists were selected as the research objects, the anti-infection treatment of the four children was analyzed and the experiences were summarized. Results: In the anti-infection consultation, clinical pharmacists provided suggestions on individualized medication from such aspects as new use of old drugs, off-label use of drugs, drug combination, and drug adverse reaction monitoring based on the special pathophysiological characteristics of children and the etiological examination results, so that the four children with difficult infections were ultimately cured and discharged from the hospital. Conclusion: Clinical pharmacists should actively analyze and summarize typical cases in the clinical practice in addition to completing their routine works, to consolidate their professional knowledge, and provide better clinical services and enable patients to receive safer and more effective treatment.